Healthpeak Properties Inc (DOC)
Official siteREAL ESTATE • REIT - HEALTHCARE FACILITIES • NYSE
Market Cap: $13.23B
Last updated: Nov 17, 2026 at 11:04 AM ET
Healthpeak Properties Inc (DOC) Financials: Revenue, Profit and Cash Flow
Healthpeak Properties reported revenue of $2.52B for the fiscal year ended Dec 31, 2025, up 4.0% from the year before. That year, net income was $101.03M with a net margin of 4.0%, operating cash flow was $1.25B and free cash flow was $1.12B. The quarter ended Sep 30, 2026 had revenue of $736.99M and net income of $36.69M.
Revenue and Margins
The operating margin was 21.6% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $1.66B, a compound annual rate of 4.7%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $2.52B | +4.0% | 25.2% | 21.6% | 4.0% |
| Dec 2024 | $2.42B | +22.2% | 67.2% | 19.5% | 11.0% |
| Dec 2023 | $1.98B | +4.9% | 64.6% | 21.9% | 16.9% |
| Dec 2022 | $1.89B | +8.6% | 63.5% | 18.9% | 27.3% |
| Dec 2021 | $1.74B | +21.8% | 64.6% | 19.6% | 30.3% |
| Dec 2020 | $1.43B | +39.5% | 60.4% | 15.1% | 30.0% |
| Dec 2019 | $1.02B | +10.0% | 81.7% | 30.0% | 5.9% |
| Dec 2018 | $930.04M | -39.6% | 87.4% | 33.5% | 115.4% |
| Dec 2017 | $1.54B | -7.5% | 76.7% | 36.3% | 27.4% |
| Dec 2016 | $1.66B | N/A | 83.5% | 43.2% | 38.4% |
Income Statement
In the fiscal year ended Dec 2025, net income fell 62.2% from the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.52B | $2.42B | $1.98B | $1.89B | $1.74B | $1.43B | $1.02B | $930.04M | $1.54B | $1.66B |
| Cost of revenue | $2.19B | $1.07B | $902.06M | $862.99M | $773.28M | $782.54M | $405.24M | $378.66M | $666.25M | $738.40M |
| Gross profit | $634.55M | $1.63B | $1.28B | $1.20B | $1.12B | $862.33M | $835.10M | $812.66M | $1.18B | $1.39B |
| Operating income | $544.13M | $471.22M | $433.91M | $356.58M | $340.32M | $215.15M | $306.94M | $311.28M | $558.63M | $719.18M |
| Net income | $101.03M | $267.30M | $334.76M | $516.42M | $525.93M | $428.25M | $60.06M | $1.07B | $422.63M | $639.93M |
| EBITDA | $1.17B | $1.00B | $874.49M | $790.49M | $756.48M | $560.95M | $740.51M | $600.06M | $625.86M | $837.96M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $736.99M | $679.30M | $665.66M | $638.76M | $629.09M | $619.28M | $630.20M | $627.48M | $626.29M | $620.59M | $545.65M | $500.87M |
| Gross profit | N/A | N/A | -$150.38M | -$627.32M | $413.95M | $418.17M | $429.75M | $420.96M | $420.12M | $421.68M | $362.83M | $329.25M |
| Operating income | N/A | N/A | $117.04M | $145.84M | $131.73M | $131.49M | $135.08M | $122.56M | $116.88M | $111.46M | $120.31M | $119.15M |
| Net income | $36.69M | $63.24M | $199.66M | $121.79M | -$109.85M | $39.02M | $50.06M | $10.67M | $92.74M | $152.72M | $11.18M | $75.39M |
Balance Sheet
As of Dec 2025, total debt of $9.85B exceeded cash and equivalents by $9.38B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $20.34B | $19.94B | $15.70B | $15.77B | $15.26B | $15.92B | $14.03B | $12.72B | $14.09B | $15.76B |
| Current assets | $1.07B | $986.14M | $561.28M | $604.97M | $713.43M | $2.98B | $188.57M | $83.70M | $88.89M | $64.44M |
| Cash and equivalents | $467.46M | $119.82M | $117.64M | $72.03M | $158.29M | $44.23M | $80.40M | $110.79M | $55.31M | $94.73M |
| Total liabilities | $12.03B | $10.88B | $8.77B | $8.48B | $8.11B | $8.57B | $7.37B | $6.21B | $8.49B | $9.82B |
| Short-term debt | $1.08B | $150.00M | $720.00M | $995.61M | $1.17B | $129.59M | $93.00M | $90.78M | $94.17M | $92.39M |
| Long-term debt | $8.77B | $8.57B | $6.16B | $5.50B | $5.00B | $6.30B | $5.91B | $5.48B | $7.79B | $9.10B |
| Shareholder equity | $7.50B | $8.40B | $6.35B | $6.65B | $6.52B | $6.73B | $6.09B | $5.94B | $5.30B | $5.55B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $22.41B | $21.68B | $21.62B | $20.34B | $19.58B | $19.81B | $19.82B | $19.94B | $19.97B | $20.18B | $20.54B | $15.70B |
| Total liabilities | $11.61B | $12.18B | $12.56B | $12.03B | $11.32B | $11.22B | $10.97B | $10.88B | $10.75B | $10.76B | $10.94B | $8.77B |
| Cash and equivalents | $514.31M | $1.63B | $1.17B | $537.70M | $91.04M | $89.44M | $70.63M | $119.82M | $180.43M | $106.89M | $101.76M | $117.64M |
| Shareholder equity | $7.87B | $7.84B | $7.83B | $7.50B | $7.60B | $7.93B | $8.19B | $8.40B | $8.56B | $8.76B | $8.88B | $6.35B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 89.6% of operating cash flow. Dividends and share repurchases together came to 84.5% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.25B | $1.07B | $956.24M | $900.26M | $795.25M | $758.43M | $846.07M | $848.71M | $847.04M | $1.21B |
| Capital expenditures | $133.95M | $115.78M | $113.60M | $108.51M | $111.48M | $94.12M | $108.84M | $106.19M | $115.26M | $91.44M |
| Free cash flow | $1.12B | $954.71M | $842.65M | $791.75M | $683.77M | $664.31M | $737.23M | $742.52M | $731.78M | $1.12B |
| Dividends paid | $849.10M | $794.78M | $657.02M | $648.05M | $650.08M | $787.07M | $720.12M | $696.91M | $694.96M | $979.54M |
| Share repurchases | $97.14M | $190.69M | $6.52M | $67.84M | $12.84M | $10.53M | $5.04M | $3.43M | $4.79M | $8.69M |
| Investing cash flow | -$1.03B | -$113.80M | -$576.75M | -$876.34M | $531.03M | -$1.01B | -$1.45B | $1.83B | $1.25B | -$428.97M |
| Financing cash flow | $136.11M | -$941.42M | -$337.30M | -$116.53M | -$1.29B | $246.45M | $647.27M | -$2.62B | -$2.15B | -$1.05B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $354.46M | $361.10M | $260.88M | $294.08M | $314.96M | $363.49M | $279.43M | $283.53M | $318.20M | $316.20M | $152.56M | $231.25M |
| Capital expenditures | $37.62M | $42.10M | $23.96M | $57.83M | $27.26M | $25.73M | $23.14M | $39.04M | $23.51M | $35.72M | $17.52M | $47.33M |
| Free cash flow | $316.84M | $319.00M | $236.93M | $236.26M | $287.70M | $337.76M | $256.29M | $244.49M | $294.69M | $280.48M | $135.05M | $183.92M |
Frequently Asked Questions About DOC
What is Healthpeak Properties' annual revenue?
Healthpeak Properties reported revenue of $2.52B for the fiscal year ended Dec 31, 2025.
How fast is Healthpeak Properties' revenue growing?
Revenue was up 4.0% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 10.1%.
Is Healthpeak Properties profitable?
Yes. Healthpeak Properties reported net income of $101.03M for the fiscal year ended Dec 31, 2025, with a net margin of 4.0%.
How much free cash flow does DOC generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $1.25B minus capital expenditures of $133.95M produced free cash flow of $1.12B.
How much debt does Healthpeak Properties have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $8.77B, short-term debt of $1.08B and cash and equivalents of $467.46M.
DOC pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors